Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
50
GILD Quote, Financials, Valuation and Earnings
Last price:
$108.78
Seasonality move
:
8.96%
Day range:
$108.57 - $110.72
52-week range:
$70.78 - $119.96
Dividend yield:
2.84%
P/E ratio:
23.13x
P/S ratio:
4.82x
P/B ratio:
7.13x
Volume:
4M
Avg. volume:
7.9M
1-year change:
53.34%
Market cap:
$136.6B
Revenue:
$28.8B
EPS (TTM):
$4.75
Earnings Data
Next earnings date for GILD
Aug 08
2025
Most recent earnings per share
$1.04
Missed by $0.73
(Apr 24/2025)
Consensus Estimate
$1.77
(Apr 24/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
GILD Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $7.4B | -- | -- | $2.17 | -- |
| 08/08/2025 | Q2 | $6.9B | -- | -- | $1.96 | -- |
| 04/24/2025 | Q1 | $6.8B | $6.7B | $1.04 | $1.77 | -$0.73 |
| 02/11/2025 | Q4 | $7.2B | $7.6B | $1.42 | $1.70 | -$0.28 |
| 11/06/2024 | Q3 | $7B | $7.5B | $1.00 | $1.55 | -$0.55 |
| 08/08/2024 | Q2 | $6.7B | $7B | $1.29 | $1.60 | -$0.31 |
| 04/25/2024 | Q1 | $6.3B | $6.7B | -$3.34 | -$1.52 | -$1.82 |
| 02/06/2024 | Q4 | $7.1B | $7.1B | $1.14 | $1.76 | -$0.62 |
| 11/07/2023 | Q3 | $6.8B | $7.1B | $1.73 | $1.92 | -$0.19 |
| 08/03/2023 | Q2 | $6.5B | $6.6B | $0.83 | $1.64 | -$0.81 |
| 04/27/2023 | Q1 | -- | $6.4B | $0.80 | -- | -- |
| 02/02/2023 | Q4 | -- | $7.4B | $1.30 | -- | -- |
| 10/27/2022 | Q3 | -- | $7B | $1.42 | -- | -- |
| 08/02/2022 | Q2 | -- | $6.3B | $0.91 | -- | -- |
| 04/28/2022 | Q1 | -- | $6.6B | $0.02 | -- | -- |
| 02/01/2022 | Q4 | -- | $7.2B | $0.30 | -- | -- |
| 10/28/2021 | Q3 | -- | $7.4B | $2.05 | -- | -- |
| 07/29/2021 | Q2 | -- | $6.2B | $1.21 | -- | -- |
| 04/29/2021 | Q1 | -- | $6.4B | $1.37 | -- | -- |
| 02/04/2021 | Q4 | -- | $7.4B | $1.23 | -- | -- |
| 10/28/2020 | Q3 | -- | $6.6B | $0.29 | -- | -- |
| 07/30/2020 | Q2 | -- | $5.1B | -$2.66 | -- | -- |
| 04/30/2020 | Q1 | -- | $5.5B | $1.22 | -- | -- |
| 02/04/2020 | Q4 | -- | $5.9B | $2.12 | -- | -- |
| 10/24/2019 | Q3 | -- | $5.6B | -$0.92 | -- | -- |
| 07/30/2019 | Q2 | -- | $5.7B | $1.47 | -- | -- |
| 05/02/2019 | Q1 | -- | $5.3B | $1.54 | -- | -- |
| 02/04/2019 | Q4 | -- | $5.8B | $0.00 | -- | -- |
| 10/25/2018 | Q3 | -- | $5.6B | $1.60 | -- | -- |
| 07/25/2018 | Q2 | -- | $5.6B | $1.39 | -- | -- |
| 05/01/2018 | Q1 | -- | $5.1B | $1.17 | -- | -- |
| 02/06/2018 | Q4 | -- | $5.9B | -$2.96 | -- | -- |
| 10/26/2017 | Q3 | -- | $6.5B | $2.06 | -- | -- |
| 07/26/2017 | Q2 | -- | $7.1B | $2.33 | -- | -- |
| 05/02/2017 | Q1 | -- | $6.5B | $2.05 | -- | -- |
| 02/07/2017 | Q4 | -- | $7.3B | $2.34 | -- | -- |
| 11/01/2016 | Q3 | -- | $7.5B | $2.49 | -- | -- |
| 07/25/2016 | Q2 | -- | $7.8B | $2.58 | -- | -- |
| 04/28/2016 | Q1 | -- | $7.8B | $2.53 | -- | -- |
| 02/02/2016 | Q4 | -- | $8.5B | $3.18 | -- | -- |
| 10/27/2015 | Q3 | -- | $8.3B | $3.06 | -- | -- |
Gilead Sciences Earnings Questions
-
How Much did Gilead Sciences Generate in Revenue Last Quarter?
Gilead Sciences reported $6.7B worth of top line sales in its most recent quarter.
-
Did Gilead Sciences Beat Earnings Last Quarter?
Gilead Sciences announced earnings per share of $1.04 which represents a miss of analyst forecast a $1.77 per share.
-
Is Gilead Sciences Profitable?
Gilead Sciences reported $5.1B that represents $4.07 per share over the last quarter.
-
What is the Analyst Consensus for Gilead Sciences EPS Next Year?
Gilead Sciences's earnings are forecast to grow from $0.38 per share to $4.41 per share next year representing an increase of 2000.11%.
-
When is Gilead Sciences's Earnings Date?
Gilead Sciences's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
